SINEUP
LIVE

Serial Number

79307287

Owner

Harness Therapeutics Limited

Attorney

Rebecca Liebowitz

Filing Date

Jan 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SINEUP Trademark

Serial Number: 79307287 • Registration: 6965967

SINEUP is a trademark filed by Harness Therapeutics Limited on January 22, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Harness Therapeutics Limited (4 trademarks)

Minerva Building (B250),

Entity Type: 98

Transine Therapeutics Limited (2 trademarks)

30 Broad Street,

Entity Type: 99

Trademark Details

Filing Date

January 22, 2021

Registration Date

January 31, 2023

Published for Opposition

November 15, 2022

Goods & Services

Pharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents, namely, DNA and RNA sequences and gene editing enzymes, all for medical use; DNA and RNA products for medical use, namely, nucleic acid sequences for medical purposes; therapeutic DNA and RNA, namely, nucleic acid sequences for medical purposes

chemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for research use, namely, nucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research use, namely, nucleic acid sequences for laboratory use, nucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNA, reagents for scientific purposes, other than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNA, namely, enzymes for scientific and research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 21, 2025 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 2, 2024 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 4, 2023 FICS
FINAL DISPOSITION PROCESSED
May 4, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 31, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 31, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 15, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Nov 14, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 26, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 26, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 13, 2022 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 20, 2022 OPNX
ASSIGNED TO EXAMINER
Sep 7, 2022 DOCK
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 31, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 31, 2022 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 20, 2022 ERFR
ASSIGNED TO EXAMINER
Jul 15, 2022 DOCK
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 14, 2022 GNFN
FINAL REFUSAL E-MAILED
Apr 14, 2022 GNFR
FINAL REFUSAL WRITTEN
Apr 14, 2022 CNFR
ASSIGNED TO EXAMINER
Mar 14, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2022 TROA
REFUSAL PROCESSED BY IB
Sep 11, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 25, 2021 RFCS
REFUSAL PROCESSED BY MPU
Aug 25, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 12, 2021 RFCR
NON-FINAL ACTION WRITTEN
Aug 11, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 9, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 2, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 29, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 25, 2021 REPR